Alpelisib - OmicsDI

Show results for

Unknown (242)
Genomics (44)
Transcriptomics (26)
Proteomics (6)
Metabolomics (3)
Clinical (2)
Other (2)

Organisms

Homo sapiens (30)
Mus musculus (6)
Alphavirus (5)
Anemia (5)
Archaea (5)
Bacteria (5)
Betaherpesvirinae (5)
Borrelia (5)
Clostridium perfringens (5)
Cytomegalovirus (5)
Dengue virus (5)
Eukaryota (5)
Hepatitis B virus (5)
Human alphaherpesvirus 1 (5)
Human betaherpesvirus 5 (5)
Human immunodeficiency virus (5)
Influenza A virus (5)
Influenza C virus (5)
Japanese encephalitis virus group (5)
Kamptonema sp. (5)
Listeria monocytogenes (5)
Mammarenavirus (5)
Miscanthus x giganteus (5)
Mycobacterium tuberculosis (5)
Orthoflavivirus (5)
Pseudomonas aeruginosa (5)
Rattus (5)
Sarbecovirus (5)
Severe acute respiratory syndrome coronavirus 2 (5)
Staphylococcus aureus (5)

Organisms

Homo sapiens (26)
Mus musculus (4)

Repository

ENA (40)
geo (28)
pride (5)
MetaboLights (3)
biostudies-arrayexpress (2)
EGA (2)
jPOST (1)

Tissue

Cell culture (4)
Epithelial cell (2)
Primary cell (1)

Disease

Breast cancer (2)
Colorectal Neoplasms (1)
Neoplasms (1)
Malignant neoplasm of ovary (1)

Technology Type

Mass Spectrometry (5)
Mass spectrometry assay (2)
Bottom-up proteomics (2)
Data-dependent acquisition (2)
Mass spectrometry (1)
Data-independent acquisition (1)
Shotgun proteomics (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (2)
Liquid Chromatography MS - positive - reverse phase (2)
Liquid Chromatography MS - alternating - hilic (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2025 (10)
2024 (9)
2023 (7)
2026 (5)
2022 (5)
2015 (2)
2021 (1)

Metabolite Name

Lysope(19:0)-d5 (1)
2,3-diaminopyridine (1)
Eugenyl glucoside (1)
NeuNGc (1)
Fructose lactate (1)
Hyp-gamma-Glu (1)
Ethyl 2-amino-3-sulfanylpropanoate (1)
6-chloro-n2,n3-diethylquinoxaline-2,3-diamine (1)
Glutamine betaine (1)
7-acetoxy-4-methylcoumarin (1)
Penmacric acid (1)
Cyanidin 3-O-(2'-xylosyl-6'-(6''-caffeoyl-glucosyl)-galactoside) (1)
[5-(2-thienyl)-3-isoxazolyl]methanol (1)
Cyclopropyl-[(6R)-6-(4-methylsulfonylphenoxy)-1,4-oxazepan-4-yl]methanone (1)
4-pyridin-3-yl-3,4-dihydro[1,3,5]triazino[1,2-a]benzimidazol-2-amine (1)
2-[(2-amino-6-methylpyrimidin-4-yl)thio]-4,6-dimethylnicotinonitrile (1)
1,6-diisocyanatohexane (1)
Val-Abu-OH (1)
N-Acetyl-D-mannosamine 6-phosphate (1)
3-Deoxyglucosone (1)
1-(2,2-Difluoroethyl)pyrrolidine-3,4-dicarboxylic acid (1)
4-Nitrophenyl maltopentaoside (1)
2-dehydropantoate (1)
Sinapoyltyramine (1)
Beta-L-Arabinose 1-phosphate (1)
4-(4-Fluorobenzyl)-2-p-tolyl-1,2,4-thiadiazolidine-3,5-dione (1)
1-(2-chlorobenzyl)-3,6-diphenylthieno[2,3-d]pyrimidine-2,4(1H,3H)-dione (1)
2-((3,5-Dihydroxyphenyl)amino)acetic acid (1)
Okanin-4'-o-glucoside (1)
Alpha-Cephalin (1)

First Public Date

2025 (11)
2024 (9)
2023 (8)
2022 (6)
2026 (4)
2021 (2)

Study status

Active, not recruiting (1)
Not yet recruiting (1)

Study type

Interventional (2)
Transcription profiling by array (1)
RNA-seq of coding RNA (1)

Release Date

2025 (46)
2024 (38)
2022 (37)
2023 (35)
2021 (35)
2020 (26)
2019 (15)
2018 (4)
2017 (4)
2015 (2)
2026 (2)

Lab affiliation

Department of Oncology-Pathology, Karolinska Institutet, 171 77 Stockholm, Sweden Institute of Molecular and Cell Biology, A*STAR, Singapore 138673, Singapore (2)
Biomolecular Mass Spectrometry and Proteomics, Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, the Netherlands (1)
Cancer Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria 3800, Australia. (1)
University of Copenhagen Faculty of Health and Medical Sciences Novo Nordisk Foundation Center for Protein Research Proteomics Program Copenhagen N Denmark (1)

Location

South Korea (2)

Keyword

Capecitabine (1)

Previous page
1 / 33
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 33
Next page

Sort by:

Relevance

Page size

Transcriptomic analysis of Nintedanib, Alpelisib and Nintedanib Alpelisib treated bladder tumors

PRJNA904345 | ENA

Transcriptomic analysis of Nintedanib, Alpelisib and Nintedanib Alpelisib treated bladder tumors

PRJNA758030 | ENA

Phosphoproteomics of BYL719 (alpelisib)-Resistant T47D Human Breast Cancer Cell Line

The PI3Kalpha-specific inhibitor Alpelisib (BYL719) has been approved for the treatment of metastatic ER+/HER2- breast cancer patients in combination with Fulvestrant. After initial response, patients develop drug resistance and disease relapses. In order to identify signalling pathways contributing...

ORGANISM(S): Homo sapiens (Human)

2023-12-05 | PXD033956 | Pride

Effect of Alpelisib treatment and MAEA knockout on gene expression of the EBV+ gastric cancer cell line YCCEL1

PRJNA1133051 | ENA

Beyond Skin Rash: Alpelisib-Induced Anaphylactic Reactions.

Not available

S-EPMC10322120 | biostudies-literature

Effect of Alpelisib treatment and MAEA knockout on gene expression of the EBV+ gastric cancer cell line YCCEL1

EBV+ gastric cancer cell line was reported with PI3K pathway activated. Alpelisib is the PIK3CA specific inhibitor. To study the MAEA knockout and alpelisib treatment, RNAseq was conducted to study the gene expression changes in YCCEL1.

ORGANISM(S): Homo sapiens

2025-10-08 | GSE271762 | GEO

Alpelisib combination treatment as novel targeted therapy against hepatocellular carcinoma.

Not available

S-EPMC8501067 | biostudies-literature

Effect of Alpelisib treatment and PIK3CA knockout on gene expression of the EBV+ gastric cancer cell line YCCEL1

PRJNA1133048 | ENA

Alpelisib-Induced Diabetic Ketoacidosis in a Non-diabetic Patient.

Not available

S-EPMC8648282 | biostudies-literature

Effects of alpelisib treatment on murine Pten-deficient lipomas.

Not available

S-EPMC11844927 | biostudies-literature

Previous page
1 / 33
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 33
Next page

Sort by:

Relevance

Page size

325 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

Metabolite Name

First Public Date

Study status

Study type

Release Date

Lab affiliation

Location

Tags

Keyword

OmicsDI is part of the ELIXIR infrastructure

Tweets